2.2. Study Design
NAFLD
This was a parallel group randomized controlled clinical trial. The inclusion criteria were (1) Body Mass Index (BMI) ≥ 25.0, (2) participants aged 30–60 years old, and (3) presence of moderate or severe NAFLD as assessed by FibroScan